ACTRIMS 2020: Subcutaneous, Monthly Ofatumumab Depletes B-Cells in Relapsing MS Rapidly Via a Convenient Pen
The medication can help reduce treatment burden.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.